Valuation: PolyNovo Limited

Market Cap 691M 484M 423M 390M 358M 679M 46.52B 4.66B 1.83B 22.74B 1.82B 1.78B 78.38B P/E 2026 *
92.3x
P/E 2027 * 35.4x
Enterprise Value 665M 466M 407M 376M 345M 654M 44.8B 4.48B 1.76B 21.9B 1.75B 1.71B 75.48B EV / Sales 2026 *
4.39x
EV / Sales 2027 * 3.58x
Free-Float
88.97%
Yield 2026 *
-
Yield 2027 * -
1 day+1.25%
1 week-2.17%
Current month+10.05%
1 month+4.38%
3 months+1.25%
6 months-15.98%
Current year-17.68%
1 week 1
Extreme 1
1.04
1 month 0.9
Extreme 0.905
1.05
Current year 0.86
Extreme 0.865
1.3
1 year 0.86
Extreme 0.865
1.66
3 years 0.86
Extreme 0.865
2.78
5 years 0.84
Extreme 0.835
2.78
10 years 0.17
Extreme 0.17
4.08
Manager TitleAgeSince
Chief Executive Officer - 2025-11-30
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman - 2025-10-26
Director/Board Member 65 2019-10-27
Director/Board Member - 2020-05-12
Date Insider Type Main position Quantity % Market Cap.
03-15Buy

Director

151,000 0.0219%
02-26Buy

Director

100,000 0.0145%
02-26Buy

Chairman

30,000 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-2.17%-15.27%-37.88% 484M
+1.06%-6.21%-32.11%-17.29% 155B
+1.48%-1.88%-9.81%-8.19% 103B
-1.89%-4.20%+0.65%+54.93% 57.7B
-1.11%+1.05%+37.77%+53.57% 52.27B
+2.81%+2.87%-13.14%-40.29% 42.68B
+2.02%-2.13% - - 33.35B
-1.88%-1.80%-14.21%-47.04% 28.06B
+0.38%+1.50%+62.41%-6.78% 25.36B
+0.27%+9.00%-3.82%-17.97% 21.03B
Average +0.34%+0.25%+1.39%-7.44% 51.94B
Weighted average by Cap. +0.30%-1.71%-7.11%-2.41%

Financials

2026 *2027 *
Net sales 152M 106M 92.74M 85.55M 78.65M 149M 10.21B 1.02B 401M 4.99B 398M 390M 17.2B 181M 127M 111M 102M 94.15M 178M 12.22B 1.22B 480M 5.97B 477M 466M 20.59B
Net income 7.01M 4.91M 4.29M 3.96M 3.64M 6.9M 472M 47.26M 18.54M 231M 18.43M 18.03M 796M 19.31M 13.51M 11.82M 10.9M 10.02M 18.99M 1.3B 130M 51.06M 636M 50.75M 49.64M 2.19B
Net Debt -25.56M -17.89M -15.64M -14.43M -13.26M -25.13M -1.72B -172M -67.59M -841M -67.19M -65.71M -2.9B -41.66M -29.15M -25.49M -23.51M -21.61M -40.96M -2.81B -281M -110M -1.37B -109M -107M -4.73B
Logo PolyNovo Limited
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.
Employees
301
Date Price Change Volume
26-07-16 A$1.013 +1.25% 365,563
26-07-15 A$1.000 -2.44% 1,351,611
26-07-14 A$1.025 +0.49% 629,971
26-07-13 A$1.020 +0.49% 1,114,559
26-07-10 A$1.015 -1.93% 1,077,022
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1.000AUD
Average target price
1.705AUD
Spread / Average Target
+70.48%

Quarterly revenue - Rate of surprise